| Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma JP Leonard, AS LaCasce, MR Smith, A Noy, LR Chirieac, SJ Rodig, ... Blood, The Journal of the American Society of Hematology 119 (20), 4597-4607, 2012 | 342 | 2012 |
| 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer R Kumar, Y Xiu, QY Jian, A Takalkar, G El-Haddad, S Potenta, J Kung, ... Journal of Nuclear Medicine 45 (12), 2058-2062, 2004 | 267 | 2004 |
| Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial CR Divgi, RG Uzzo, C Gatsonis, R Bartz, S Treutner, JQ Yu, D Chen, ... Journal of clinical oncology 31 (2), 187, 2013 | 238 | 2013 |
| Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders H Zhuang, QY Jian, A Alavi Radiologic Clinics 43 (1), 121-134, 2005 | 210 | 2005 |
| Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes A Mavi, M Urhan, QY Jian, H Zhuang, M Houseni, TF Cermik, ... Journal of Nuclear Medicine 47 (9), 1440-1446, 2006 | 196 | 2006 |
| NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer DA Podoloff, RH Advani, C Allred, AB Benson, E Brown, HJ Burstein, ... Journal of the National Comprehensive Cancer Network 5 (S1), S-1-S-22, 2007 | 169 | 2007 |
| The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial. SBA Andriole GL, Kostakoglu L, Chau A, Duan F, Mahmood U, Mankoff DA ... J Urol 201 (2), 322-331, 2019 | 149 | 2019 |
| Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity Y Xiu, C Bhutani, T Dhurairaj, QY Jian, S Dadparvar, S Reddy, R Kumar, ... Clinical nuclear medicine 32 (2), 101-105, 2007 | 145 | 2007 |
| The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions A Mavi, TF Cermik, M Urhan, H Puskulcu, S Basu, QY Jian, H Zhuang, ... Journal of Nuclear Medicine 48 (8), 1266-1272, 2007 | 110 | 2007 |
| Clinical presentation and staging of melanoma WH Ward, F Lambreton, N Goel, JQ Yu, JM Farma | 109 | 2018 |
| Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans M Doss, HC Kolb, JJ Zhang, MJ Bélanger, JB Stubbs, MG Stabin, ... Journal of Nuclear Medicine 53 (5), 787-795, 2012 | 109 | 2012 |
| Repeatability of 18F-FDG PET/CT in advanced non–small cell lung cancer: prospective assessment in 2 multicenter trials WA Weber, CA Gatsonis, PD Mozley, LG Hanna, AF Shields, DR Aberle, ... Journal of Nuclear Medicine 56 (8), 1137-1143, 2015 | 103 | 2015 |
| F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas M Hernandez-Pampaloni, A Takalkar, JQ Yu, H Zhuang, A Alavi Pediatric radiology 36, 524-531, 2006 | 102 | 2006 |
| Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression M Lango, D Flieder, R Arrangoiz, C Veloski, JQ Yu, T Li, B Burtness, ... Thyroid 23 (9), 1099-1105, 2013 | 101 | 2013 |
| 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas R Kumar, Y Xiu, S Potenta, A Mavi, H Zhuang, QY Jian, T Dhurairaj, ... Journal of Nuclear Medicine 45 (11), 1796-1803, 2004 | 97 | 2004 |
| Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive … VJ Lowe, F Duan, RM Subramaniam, JRD Sicks, J Romanoff, T Bartel, ... Journal of Clinical Oncology 37 (20), 1704-1712, 2019 | 91 | 2019 |
| Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for … A Konski, T Li, M Christensen, JD Cheng, QY Jian, K Crawford, ... Radiotherapy and Oncology 104 (1), 72-77, 2012 | 76 | 2012 |
| Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy Y Xiu, QY Jian, E Cheng, R Kumar, A Alavi, H Zhuang Clinical nuclear medicine 30 (3), 193-195, 2005 | 73 | 2005 |
| Biodistribution and radiation dosimetry of the hypoxia marker 18F–HX4 in monkeys and humans determined by using whole-body PET/CT M Doss, JJ Zhang, MJ Bélanger, JB Stubbs, ED Hostetler, K Alpaugh, ... Nuclear medicine communications 31 (12), 1016-1024, 2010 | 66 | 2010 |
| Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation A Konski, T Li, E Sigurdson, SJ Cohen, W Small Jr, S Spies, QY Jian, ... International Journal of Radiation Oncology* Biology* Physics 74 (1), 55-59, 2009 | 61 | 2009 |
Abass AlaviUPENNПотвърден имейл адрес: uphs.upenn.edu
